Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
14.08
+0.18 (1.30%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Gyre Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Revenue | 111.59 | 113.45 | 102.29 |
Revenue Growth (YoY) | -1.63% | 10.91% | - |
Cost of Revenue | 4.18 | 4.64 | 4.79 |
Gross Profit | 107.4 | 108.81 | 97.5 |
Selling, General & Admin | 75.38 | 75.82 | 71.61 |
Research & Development | 13.11 | 13.78 | 16.69 |
Operating Expenses | 88.5 | 89.6 | 88.29 |
Operating Income | 18.91 | 19.21 | 9.2 |
Interest & Investment Income | 1.29 | 1.04 | 0.73 |
Earnings From Equity Investments | -1.31 | -1.31 | -0.25 |
Currency Exchange Gain (Loss) | -1.5 | -1.5 | -4.9 |
Other Non Operating Income (Expenses) | -2.44 | -8.97 | 3.73 |
EBT Excluding Unusual Items | 14.94 | 8.48 | 8.51 |
Gain (Loss) on Sale of Assets | -3.41 | -3.34 | - |
Other Unusual Items | 1 | 1 | 0.9 |
Pretax Income | -70.57 | -76.97 | 9.41 |
Income Tax Expense | 8.42 | 8.52 | 5.1 |
Earnings From Continuing Operations | -78.99 | -85.48 | 4.31 |
Minority Interest in Earnings | -6.98 | -7.45 | -2.01 |
Net Income | -85.97 | -92.93 | 2.3 |
Net Income to Common | -85.97 | -92.93 | 2.3 |
Shares Outstanding (Basic) | 76 | 66 | 64 |
Shares Outstanding (Diluted) | 76 | 66 | 76 |
Shares Change (YoY) | 19.88% | -13.02% | - |
EPS (Basic) | -1.13 | -1.41 | 0.04 |
EPS (Diluted) | -1.22 | -1.41 | 0.03 |
Free Cash Flow | 2.35 | 17.38 | 5.69 |
Free Cash Flow Per Share | 0.03 | 0.26 | 0.08 |
Gross Margin | 96.25% | 95.91% | 95.31% |
Operating Margin | 16.94% | 16.94% | 9.00% |
Profit Margin | -77.04% | -81.92% | 2.25% |
Free Cash Flow Margin | 2.10% | 15.32% | 5.56% |
EBITDA | 20.08 | 20.33 | 10.33 |
EBITDA Margin | 18.00% | 17.92% | 10.10% |
D&A For EBITDA | 1.17 | 1.11 | 1.13 |
EBIT | 18.91 | 19.21 | 9.2 |
EBIT Margin | 16.94% | 16.94% | 9.00% |
Effective Tax Rate | - | - | 54.16% |
Source: S&P Capital IQ. Standard template.
Financial Sources.